Arrowhead Pharmaceuticals, Inc. ( ARWR) - Key Metrics
ARWR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $0.52 | -$1.36 | -$1.24 | -$1.26 |
| 2026Q2 | $0.52 | -$0.93 | $0.59 | $0.57 |
| 2026Q1 | $1.89 | $0.22 | $0.10 | $0.08 |
| 2025Q4 | $1.89 | -$0.18 | $0.15 | $0.10 |
| 2025Q3 | $0.20 | -$1.26 | -$1.11 | -$1.13 |
ARWR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | -19.78% | -14.98 |
| 2026Q2 | 0% | -16.85 |
| 2026Q1 | 0% | 75.44 |
| 2025Q4 | 0% | -50.72 |
| 2025Q3 | 0% | -3.13 |
ARWR Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q3 | -1.55% | 0.33% |
| 2026Q2 | 0.92% | 0% |
| 2026Q1 | 0.12% | 0% |
| 2025Q4 | 0.28% | 0% |
| 2025Q3 | -7.15% | 0% |
ARWR
Price: $86.64
52 week price:
Earnings Per Share: -2.28 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 594870
Ebitda: -12.7 millionMarket Capitalization: 12.5 billion